GlassScriptPhysician profile
Nicholas Mark Romansky
NPI 1912992991
$686.90
in general payments reported to CMS, 2019-2025
11 companies · $23.96 in 2025
The $23.96 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $118 · 2021: $29.00 · 2022: $119 · 2023: $220 · 2024: $178 · 2025: $23.96.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $422.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $421.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Next Science LLC | $263.03 | 2022-2023 | Xperience, Blastx, Surgx |
| Arthrosurface Incorporated | $104.83 | 2020 | |
| Stryker Corporation | $85.93 | 2024 | Ortholoc 3di |
| Fusion Orthopedics USA, LLC | $61.43 | 2024 | |
| Abbvie INC. | $55.04 | 2023-2024 | Dalvance |
| Bioventus LLC | $30.05 | 2023 | Exogen Ultrasound Bone Healing System |
| Alexion Pharmaceuticals, INC. | $23.96 | 2025 | Strensiq |
| Averitas Pharma INC. | $20.90 | 2023 | Qutenza |
| Organogenesis INC. | $15.62 | 2021 | |
| Horizon Therapeutics Plc | $13.38 | 2021 | |
| Zyla Life Sciences, INC. | $12.73 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Romansky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.